Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $4.98 billion. The enterprise value is $2.74 billion.
Important Dates
The next confirmed earnings date is Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 258.24 million shares outstanding. The number of shares has decreased by -4.81% in one year.
| Current Share Class | 222.73M |
| Shares Outstanding | 258.24M |
| Shares Change (YoY) | -4.81% |
| Shares Change (QoQ) | -16.48% |
| Owned by Insiders (%) | 3.47% |
| Owned by Institutions (%) | 62.43% |
| Float | 210.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| Forward PS | 0.41 |
| PB Ratio | 4.30 |
| P/TBV Ratio | 4.30 |
| P/FCF Ratio | 4.15 |
| P/OCF Ratio | 4.04 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.28 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.31.
| Current Ratio | 0.89 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.30 |
| Interest Coverage | -5.47 |
Financial Efficiency
Return on equity (ROE) is -13.96% and return on invested capital (ROIC) is -5.35%.
| Return on Equity (ROE) | -13.96% |
| Return on Assets (ROA) | -1.42% |
| Return on Invested Capital (ROIC) | -5.35% |
| Return on Capital Employed (ROCE) | -8.53% |
| Revenue Per Employee | $4.47M |
| Profits Per Employee | -$67,180 |
| Employee Count | 2,400 |
| Asset Turnover | 1.88 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $9.33 million in taxes.
| Income Tax | 9.33M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.02% in the last 52 weeks. The beta is 1.89, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.89 |
| 52-Week Price Change | +21.02% |
| 50-Day Moving Average | 18.85 |
| 200-Day Moving Average | 15.90 |
| Relative Strength Index (RSI) | 47.60 |
| Average Volume (20 Days) | 19,312,205 |
Short Selling Information
The latest short interest is 38.39 million, so 14.86% of the outstanding shares have been sold short.
| Short Interest | 38.39M |
| Short Previous Month | 34.58M |
| Short % of Shares Out | 14.86% |
| Short % of Float | 18.27% |
| Short Ratio (days to cover) | 1.97 |
Income Statement
In the last 12 months, Oscar Health had revenue of $10.73 billion and -$161.23 million in losses. Loss per share was -$0.69.
| Revenue | 10.73B |
| Gross Profit | 1.84B |
| Operating Income | -129.47M |
| Pretax Income | -151.33M |
| Net Income | -161.23M |
| EBITDA | -99.03M |
| EBIT | -129.47M |
| Loss Per Share | -$0.69 |
Full Income StatementBalance Sheet
The company has $3.54 billion in cash and $357.22 million in debt, giving a net cash position of $2.24 billion or $8.68 per share.
| Cash & Cash Equivalents | 3.54B |
| Total Debt | 357.22M |
| Net Cash | 2.24B |
| Net Cash Per Share | $8.68 |
| Equity (Book Value) | 1.16B |
| Book Value Per Share | 4.49 |
| Working Capital | -552.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.23 billion and capital expenditures -$32.69 million, giving a free cash flow of $1.20 billion.
| Operating Cash Flow | 1.23B |
| Capital Expenditures | -32.69M |
| Free Cash Flow | 1.20B |
| FCF Per Share | $4.65 |
Full Cash Flow StatementMargins
Gross margin is 17.20%, with operating and profit margins of -1.21% and -1.50%.
| Gross Margin | 17.20% |
| Operating Margin | -1.21% |
| Pretax Margin | -1.41% |
| Profit Margin | -1.50% |
| EBITDA Margin | -0.92% |
| EBIT Margin | -1.21% |
| FCF Margin | 11.20% |
Dividends & Yields
Oscar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.81% |
| Shareholder Yield | 4.81% |
| Earnings Yield | -3.24% |
| FCF Yield | 24.12% |
Dividend DetailsAnalyst Forecast
The average price target for Oscar Health is $13.19, which is -31.62% lower than the current price. The consensus rating is "Sell".
| Price Target | $13.19 |
| Price Target Difference | -31.62% |
| Analyst Consensus | Sell |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
